Education
About Us
Working with TipRanks
Follow Us
Harrow Health Inc (HROW)
NASDAQ:HROW
Total Valuation
Harrow Health has a market cap or net worth of $888.15M. The enterprise value is $1.38B.
Market Cap$888.15M
Enterprise Value$1.38B
Share Statistics
Harrow Health has 35.65M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35.65M
Owened by Insiders12.15%
Owened by Instutions27.90%
Financial Efficiency
Harrow Health’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 2.94%.
Return on Equity (ROE)>-0.01%
Return on Assets (ROA)>-0.01%
Return on Invested Capital (ROIC)2.94%
Return on Capital Employed (ROCE)2.96%
Revenue Per Employee$522,549.738
Profits Per Employee-$45,761.78
Employee Count382
Asset Turnover0.51
Inventory Turnover4.60
Valuation Ratios
The current PE Ratio of Harrow Health is -68.42. Harrow Health’s PEG ratio is 1.97.
PE Ratio-68.42
PS Ratio<0.01
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF-19.65
Price to Operating Cash Flow-53.87
PEG Ratio1.97
Income Statement
In the last 12 months, Harrow Health had revenue of $199.61M and earned -$17.48M in profits. Earnings per share was -$0.49.
Revenue$199.61M
Gross Profit$150.37M
Operating Income$8.82M
Pretax Income-$16.29M
Net Income-$17.48M
EBITDA20.00M
Earnings Per Share (EPS)-0.49
Cash Flow
In the last 12 months, operating cash flow was -$22.20M and capital expenditures -$38.60M, giving a free cash flow of -$60.80M billion.
Operating Cash Flow-$22.20M
Free Cash Flow-$60.80M
Free Cash Flow per Share-$1.71
Dividends & Yields
Harrow Health pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-5.09%
Earnings Yield-1.46%
Stock Price Statistics
Beta1.73
52-Week Price Change90.43%
50-Day Moving Average27.14
200-Day Moving Average35.36
Relative Strength Index (RSI)41.62
Average Volume (3m)666.97K
Important Dates
Harrow Health upcoming earnings date is May 19, 2025, After Close.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Harrow Health as a current ratio of 2.08, with Debt / Equity ratio of <0.01
Current Ratio2.08
Quick Ratio1.96
Debt to Market Cap0.18
Net Debt to EBITDA<0.01
Interest Coverage Ratio387.17K
Taxes
In the past 12 months, Harrow Health has paid $4.33M in taxes.
Income Tax$4.33M
Effective Tax Rate0.93%
Enterprise Valuation
Harrow Health EV to EBITDA ratio is <0.01, with an EV/FCF ratio of -22.63.
EV to Sales<0.01
EV to EBITDA<0.01
EV to Free Cash Flow-22.63
EV to Operating Cash Flow-62.05
Balance Sheet
Harrow Health has $47.25M in cash and marketable securities with $228.83M in debt, giving a net cash position of $181.58M billion.
Cash & Marketable Securities$47.25M
Total Debt$228.83M
Net Cash$181.58M
Net Cash Per Share$5.09
Tangible Book Value Per Share$1.94M
Margins
Gross margin is 75.33%, with operating margin of 4.42%, and net profit margin of >-0.01%.
Gross Margin75.33%
Operating Margin4.42%
Pretax Margin-8.68%
Net Profit Margin>-0.01%
EBITDA Margin4.42%
EBIT Margin<0.01%
Analyst Forecast
The average price target for Harrow Health is $59.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$59.00
Price Target Upside144.91%
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast53.32%
EPS Growth Forecast33.82%